OCIAD2 and adenocarcinoma in situ: The expression of OCIAD2 was highly expressed in the invasive adenocarcinoma than in the in situ adenocarcinoma in lung cancer, whereas the expression level is significantly reduced in liver cancer and gastric stroma carcinoma, when compared with that in the corresponding normal tissues (42, 43).